1-12859722-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_023014.1(PRAMEF2):c.317G>A(p.Arg106Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000156 in 1,606,652 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_023014.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRAMEF2 | NM_023014.1 | c.317G>A | p.Arg106Gln | missense_variant | 3/4 | ENST00000240189.2 | NP_075390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRAMEF2 | ENST00000240189.2 | c.317G>A | p.Arg106Gln | missense_variant | 3/4 | 1 | NM_023014.1 | ENSP00000240189 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 150922Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248042Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134800
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1455632Hom.: 1 Cov.: 34 AF XY: 0.0000207 AC XY: 15AN XY: 724232
GnomAD4 genome AF: 0.0000265 AC: 4AN: 151020Hom.: 0 Cov.: 33 AF XY: 0.0000407 AC XY: 3AN XY: 73770
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 22, 2023 | The c.317G>A (p.R106Q) alteration is located in exon 3 (coding exon 2) of the PRAMEF2 gene. This alteration results from a G to A substitution at nucleotide position 317, causing the arginine (R) at amino acid position 106 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at